The mobilization conference of the 23rd Quality Month was held by YRPG on March 4 and the first Quality Month of this year was commenced. Liang Yuantai, General Manager Assistant, called for all the employees to monitor the drug quality, find problems and solutions so as to improve the quality control systems, serve the marketing and guarantee the enterprise’s development in a sound and rapid manner while studying the new GMP and new Pharmacopoeia of People's Republic of China.
Over 100 people, including the middle and top leaders of the group as well as principals of relevant departments such as the quality department, attended the conference, which was chaired by Sha Qi, Director of the Manufacture Department. Liang Yuantai, General Manager Assistant, reported to the conference. 
With the theme of “Implementing the new GMP, upgrading the product standards and serving the marketing”, the Quality Month activity was developed with the new GMP as the core. Efforts have been made to organize the study of Good Manufacturing Practice (the version with the second opinion soliciting) to make comparison item by item, find disparity in terms of the hardware and software and propose measures for improvement; at the same time, revision has been made to the document system in combination of the implementation of 2010 Pharmacopoeia of People's Republic of China of People's Republic of China. Efforts have been also made to track and settle important subsequent affairs of the 22nd Quality Month so as to guarantee the continuation and effectiveness of the activity.
In order to guarantee practical effects of the Quality Month, the group specially established a leading team to carry out internal and external publicity by various methods, develop the drug quality warning education and strive to perfect the quality guarantee system. The group would accept the activity effect and convene the summary conference in the middle of April to commend the units and individuals with outstanding achievements.
Good Manufacturing Practice (GMP) is the basic principle for drug production and quality management. As the new GMP would be promulgated, it would bring challenges opportunities to domestic pharmaceutical enterprises. It would be a starting point for the enterprises to eliminate the laggard and upgrade their hardware and software so as to leap forward. Therefore, the group would use the Quality Month to mobilize employees to study the new GMP, refresh the quality management concept, carry out assessment of the existing quality management system as per high standards, find the current disparities and upgrade the GMP management level on the basis of obtaining achievement in terms of the European GMP attestation of troche and capsule.
Pharmacopoeia of People's Republic of China is a pharmacopoeia of its kind, formulated with laws to guarantee the drug quality and ensure the people’s safe medication; it was a legal reference that shall be observed in terms of the drug preparation, production, operation, use and management; it was a core of the national drug standard system. The 2010 Pharmacopoeia of People's Republic of China has been promulgated and implemented since July 1, 2010.The Quality Control Department would study its innovations and changes during the Quality Month and would submit a detailed draft to lay down solid foundation for its enforcement.